NUS Links:
Glioblastoma (GBM) is the most aggressive form of solid brain tumours with limited treatment options. Nanoparticles have been shown to induce an antitumour effect and target GBM selectively. Researchers in this study, which includes N2CR member Dr Derrick Ong, provides evidence for the possible application of nanoparticles to treat GBM and other advanced-stage solid tumours.
CIITA is the master regulator of MHC class-II immune genes that are important for defense mechanism against infections and cancer …
Chemotherapy, although the first line of defense in cancer treatment, is indiscriminate and is damaging to the entire body, which, …
This research, led by N2CR members Prof Goh Boon Cher and Prof Shazib Pervaiz with Dr Jayshree Hirpara as the …